Alice Blue Home
URL copied to clipboard

Trending News

Strides Pharma Science: Stock in focus after it partners with Kenox for US Market

Strides Pharma Science Ltd has partnered with Kenox Pharmaceuticals to develop and file multiple nasal spray products for the US market, strengthening its OINDP pipeline across therapeutic areas.

Introduction

Leading pharmaceutical company has entered a strategic product development partnership with Kenox Pharmaceuticals to develop multiple nasal spray products for the US market.

Alice Blue Image

Also Read: Brigade Enterprises: Stock jumps after signing agreement for residential development in Bengaluru

Share price movement of Strides Pharma

On September 9, 2025, Strides Pharma Science Ltd opened at ₹896.95, up 1.80% from its previous close of ₹881.05. The stock reached a high of ₹897.00 and a low of ₹878.25. By 12:04 PM, it traded at ₹878.85, with a market cap of ₹8,100.60 crore.

Strides Partners with Kenox to Expand Nasal Sprays

Strides Pharma Science Ltd announced a strategic product development partnership with Kenox Pharmaceuticals Inc. The agreement involves Strides’ subsidiary, Strides Pharma Global Pte. Limited, Singapore, collaborating with Kenox on nasal spray products.

The collaboration focuses on developing and filing multiple nasal spray products for the US market. Kenox will provide formulation and development expertise in Orally Inhaled and Nasal Drug Products (OINDPs) to support the partnership.

The partnership aims to accelerate the availability of affordable, high-quality nasal spray medicines across diverse therapeutic areas. Specific product details remain confidential, and the collaboration is expected to strengthen Strides’ nasal spray pipeline.

Ace investor holding in Strides Pharma

Mukul Mahavir Agrawal holds a 1.16% stake in Strides Pharma Science Ltd, owning 1,066,000 shares valued at ₹93.7 crore.

Stock performance of Strides Pharma for Period of 1 week, 6 months, and 1 year

Strides Pharma Science Ltd delivered a -1.62% return over the past week, gained 50.0% in the past six months, and rose 43.7% over the past year.

Alice Blue Image

Also Read: Sudarshan Pharma: Stock hits upper circuit after signing agreement with Srigen Lifesciences

Shareholding pattern of Strides Pharma

ParticularsJun 2025Mar 2025Dec 2024
Promoter28.30%28.30%26.80%
FII28.00%28.30%28.50%
DII13.30%13.70%16.90%
Public30%30%27.80%

About Strides Pharma

Strides Pharma Science Ltd (NSE: STAR) is a Bengaluru-based global pharmaceutical company. It operates in regulated and donor-funded markets, manufactures complex products, and has facilities in India, Italy, Kenya, and the United States.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

Q: Why is Strides Pharma Science Ltd share price going up today?

A: Strides Pharma Science Ltd share price rose after announcing a strategic nasal spray product development partnership with Kenox Pharmaceuticals Inc.

Q: How much stake does Mukul Mahavir Agrawal hold in Strides Pharma Science Ltd stock?

A: Mukul Mahavir Agrawal holds a 1.16% stake in Strides Pharma Science Ltd, owning 1,066,000 shares valued at ₹93.7 crore.

Q: What is the 52-week high and low of Strides Pharma Science Ltd stock?

A: The 52-week high of Strides Pharma Science Ltd stock is ₹971.90, and the 52-week low is ₹530.70.

Submit the form, and get to know how you scored!!!

Gainers & Losers

Read More News

*T&C apply